attattgaagcatttatcagggttattgtctcatgagcggatacatatttgaatgtatttagaaaaataaacaaataggggttccgcgcacatttcctgcataatgaaagaccccacctgtaggtttggcaagctagcttaagtaacgccattttgcaaggcatggaaaaatacataactgagaatagaaaagttcagatcaaggtcaggaacagatggaacagctgaatatgggccaaagcggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggaacagctgaatatgggccaaacaggatatctgtggtaagcagttcctgccccggctcagggccaagaacagatggtccccagatgcggtccagccctcagcagtttctagagaaccatcagatgtttccagggtgccccaaggacctgaaatgaccctgtgccttatttgaactaaccaatcagttcgcttctcgcttctgttcgcgcgcttctgctccccgagctcaataaaagagcccacaacccctcactcgggGCGCCAGTCCTCCGATTGACTGAGTCGCCCGGGTACCCGTGTTCTCAATAAACCCTCTTGCAGTTGCATCCGACTCGTGGTCTCGCTGATCCTTGGGAGGGTCTCCTCAGATTGATTGACTGCCCACCTCGGGGGTCTTTCATTTGGAGGTTCCACCGAGATTTGGAGACCCCTGCCCAGGGACCACCGACCCCCCCGCCGGGAGGTAAGCTGGCCAGCGGTCGTTTCGTGTCTGTCTCTGTCTTTGTGCGTGTTTGTGCCGGCATCTAATGTTTGCGCCTGCGTCTGTactagtTGGCTAACTAGATCTGTATCTGGCGGTCCCGCGGAAGAACTGACGAGTTCGTATTCCCGGCCGCAGCCCCTgGGAGACGTCCCAGCGGCCTCGGGGGCCCGTTTTGTGGCCCaTTCTGTaTCaGTTAACCtACCCGAGTCGGACTTTTTGGAGCTCCGCCACTGTCCGAGGGGTACGTGGCTTTGTTGGGGGACGAGAGACAGAGACACTTCCCGCCCCCGTCTGAATTTTTGCTTTCGGTTTTACGCCGAAACCGCGCCGCGCGTCTTGTCTGCTGCAGCATCGTTCTGTGTTGTCTCTGTCTGACTGTGTTTCTGTATTTGTCTGAAAATTAGGGCCAGACTGTTACCACTCCCTTAAGTTTGACCTTAGATCACTGGAAAGATGTCGAGCGGATCGCTCACAACCAGTCGGTAGATGTCAAGAAGAGACGATGGGTTACCTTCTGCTCTGCAGAATGGCCAACCTTTAACGTCGGATGGCCGCGAGACGGCACCTTTAACCGAGACCTCATCACCCAGGTTAAGATCAAGGTCTTTTCACCTGGCCCGCATGGACACCCAGACCAGGTCCCCTACATCGTGACCTGGGAAGCCTTGGCTTTTGACCCCCCTCCCTGGGTCAAGCCCTTTGTACACCCTAAGCCTCCGCCTCCTCTTCCTCCATCCGCCCCGTCTCTCCCCCTTGAACCTCCTCTTTCGACCCCGCCTCGATCCTCCCTTTATCCAGCCCTCACTCCTTCTCTAGGCGCCACCGCGGTGGTTAATtaaatggaagcagacgccttgagcccggtggggctgggcctcctgctgctgcccttcttggtcacgctcctggctgccctgtgcgtgcgctgccgtgagttgccagctcgagtctcctatgacagcacttccacagagagtttgtacccaagaagcatcctcatcaagccacctcaaataaccgtcccccgaacacctgctgtttcctaccctctagtcacttccttcccacccctgaggcagccagacctgctccccatcccgaagaacaagatgctgttctcccaccttgaggccaacagtgtggcaagctacgagaaccagggaccggttaagccagcctgtaagaatgtggatgcagatgaggatgaagacgactatcccaacggctacctagtggtgctgcctgacagtagtcctgctgccgtccctgttgtctcctctgctcctgtgcctagcaaccctgaccttggagacagtgccttctctgtatcgattctggagtcgtgtgaagattacgtgaatgttcctgagagtgaggagagcgcagaggcgtctctggatgggagccgggagtatgtgaatgtgtccccagagcagcagccagtgaccagggctgagctggcctctgtgaactcccaggaggtggaagacgaaggagaagaggaaggggtggatggagaggaagctcccgactatgagaatctacaggagcttaactctagaGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGggatcctaaGAATTCaatcaacctctggattacaaaatttgtgaaagattgactggtattcttaactatgttgctccttttacgctatgtggatacgctgctttaatgcctttgtatcatgctattgcttcccgtatggctttcattttctcctccttgtataaatcctggttgctgtctctttatgaggagttgtggcccgttgtcaggcaacgtggcgtggtgtgcactgtgtttgctgacgcaacccccactggttggggcattgccaccacctgtcagctcctttccgggactttcgctttccccctccctattgccacggcggaactcatcgccgcctgccttgcccgctgctggacaggggctcggctgttgggcactgacaattccgtggtgttgtcggggaagctgacgtcctttccatggctgctcgcctgtgttgccacctggattctgcgcgggacgtccttctgctacgtcccttcggccctcaatccagcggaccttccttcccgcggcctgctgccggctctgcggcctcttccgcgtcttcgccttcgccctcagacgagtcggatctccctttgggccgcctccccgcctgCTCGAGCGGCCGCCAGCACAGTGGTCGAtCGACcagctgtggaatgtgtgtcagttagggtgtggaaagtccccaggctccccagcaggcagaagtatgcaaagcatgcatctcaattagtcagcaaccaggtgtggaaagtccccaggctccccagcaggcagaagtatgcaaagcatgcatctcaattagtcagcaaccatagtcccgcccctaactccgcccatcccgcccctaactccgcccagttccgcccattctccgccccatggctgactaattttttttatttatgcagaggccgaggccgcctcggcctctgagctattccagaagtagtgaggaggcttttttggaggcctaggcttttgcaaaAAGCTTACCATGACCGAGTACAAGCCCACGGTGCGCCTCGCCACCCGCGACGACGTCCCCAgggccgtacgcaccctcgccgccgcgttcgccgactaccccgccacgcgccacaccgtcgaTccggaccgccacatcgagcgggtcaccgagctgcaagaactcttcctcacgcgcgtcgggctcgacatcggcaaggtgtgggtcgcggacgacggcgccgcggtggcggtctggaccacgccggagagcgtcgaagcgggggcggtgttcgccgagatcggcccgcgcatggccgagttgagcggttcccggctggccgcgcagcaacagatggaaggcctcctggcgccgcaccggcccaaggagcccgcgtggttcctggccaccgtcggcgtctcgcccgaccaccagggcaagggtctgggcagcgccgtcgtgctccccggagtggaggcggccgagcgcgccggggtgcccgccttcctggagacctccgcGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGgccccgcaacctccccttctacgagcggctcggcttcaccgtcaccgccgacgtcgagtgcccgaaggaccgcgcgacctggtgcatgacccgcaagcccggtgcctgacgcccgccccacgacccgcagcgcccgaccgaaaggagcgcacgacccATCGTCGACgatagcgctgataaaATAaAAGATTTTATTTAGTCTCCAGAAAAAGGGGGGAATGAAAGACCCCACCTGTAGGTTTGGCAAgctagctgcagtaacgGCCATTTTGCAAGGCATGGAAAAATACCAAACCAAGAATAGAGAAGTTCAGATCAAGGGCGGGTACATGAAAATAGCTAACGTTGGGCCAAACAGGATATCTGCGGTGAGCAGTTTCGGCCCCGGCCCGGGGCCAAGAACAGATGGTCACCGCAGTTTCGGCCCCGGCCCGAGGCCAAGAACAGATGGTCCCCAGATATGGCCCAACCCTCAGCAGTTTCTTAAGACCCATCAGATGTTTCCAGGCTCCCCCAAGGACCTGAAATGACCCTGCGCCTTATTTGAATTAACCAATCAGCCTGCTTCTCGCTTCTGTTCGCGCGCTTCTGCTTCCCGAGCTCTATAAAAGAGCTCACAACCCCTCACTCGGCGCGCCAGTCCTCCGATTGACTGAGTCGCCCGGGTACCCGTATTCCCAATAAAGCCTCTTGCTGTTTGCATCCGAATCGTGGACTCGCTGATCCTTGGGAGGGTCTCCTCAGATTGATTGACTGCCCACCTCGGGGGTCTTTCAgtaacgcgtggcgctcttccgctgctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagctcactcaaaggcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccaggcgtttccccctggaagctccctcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctcccttcgggaagcgtggcgctttctcatagctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggtaactatcgtcttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgtaggcggtgctacagagttcttgaagtggtggcctaactacggctacactagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttggtagctcttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaagatcctttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaaaaggatcttcacctagatccttttGCGGCCGGCCGCaaatcaatctaaagtatatatgagtaaacttggtctgacagttaccaatgcttaatcagtgaggcacctatctcagcgatctgtctatttcgttcatccatagttgcctgactccccgtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatgataccgcgagacccacgctcaccggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtggtcctgcaactttatccgcctccatccagtctattaattgttgccgggaagctagagtaagtagttcgccagttaatagtttgcgcaacgttgttgccattgctacaggcatcgtggtgtcacgctcgtcgtttggtatggcttcattcagctccggttcccaacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaagcggttagctccttcggtcctccgatcgttgtcagaagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctcttactgtcatgccatccgtaagatgcttttctgtgactggtgagtactcaaccaagtcattctgagaatagtgtatgcggcgaccgagttgctcttgcccggcgtcaacacgggataataccgcgccacatagcagaactttaaaagtgctcatcattggaaaacgttcttcggggcgaaaactctcaaggatcttaccgctgttgagatccagttcgatgtaacccactcgtgcacccaactgatcttcagcatcttttactttcaccagcgtttctgggtgagcaaaaacaggaaggcaaaatgccgcaaaaaagggaataagggcgacacggaaatgttgaatactcatactcttcctttttcaatP kP    9 9B B    #  #      k k k k k]5 B@HѢ  >I M B@HѢ  5J5KjB B@HѢ  p&<~`( B@HѢ  ~\  B@HО    `B@HѢ  _Tt B@HѢ   P pB@HѢ   # B@HѢ  (4& P B@HѢ   ( 9 B@HѢ  &(q oB  B@HѢ  B4( p vU B@HѢ  P( "MZUs B@HѢ  l^( LVs B@HѢ  z(F tp* pB@HѢ  )M:  B@HѢ    B@HѢ  n Psi gag MESV 5'LTR MESV 9complete murine embryonic stem cell virus leader sequence 3LTR SFFVSpleen Focus Forming Virus LTR pMOWS (Robin)pcr4 cutampR -lactamasepMOWS-LtmL1L2L3-GFPopen reading frame#1GFPL1tm (LAT) 1aa-34aa>gb|BC013337.1| Mus musculus linker for activation of T cells, mRNA (cDNA clone MGC:13859 IMAGE:4191983), fragment cds ; 1-34aa (transmembran sequence) GENE ID: 16797 Lat | linker for activation of T cellsL2 (LAT) 118-169aa>gb|BC013337.1| Mus musculus linker for activation of T cells, mRNA (cDNA clone MGC:13859 IMAGE:4191983), fragment cds from118-169aa of 242aa GENE ID: 16797 Lat | linker for activation of T cellsL3 (LAT) 170-242aa>gb|BC013337.1| Mus musculus linker for activation of T cells, mRNA (cDNA clone MGC:13859 IMAGE:4191983), fragment cds from 170-242aa of 242aa GENE ID: 16797 Lat | linker for activation of T cellsL1 (LAT) 35-85aa Nex5 (LAT2) 81-91aa >ref|NM_020044.2| Mus musculus linker for activation of T cells family, member 2 (Lat2), transcript variant 1, mRNA fragment 81-91aa of 203aa gene_synonym="AW125574; Lat2; LAB; NTAL; Wbscr15; Wbscr5; WSCR5 L1 (LAT) 106-116aa>gb|BC013337.1| Mus musculus linker for activation of T cells, mRNA (cDNA clone MGC:13859 IMAGE:4191983), mRNA fragment aa 106-116 of of 242aa GENE ID: 16797 Lat | linker for activation of T cellspuroDemb|CAA68909.1| puromycin N-acetyltransferase [synthetic construct]WPRECWoodchuck hepatitis B Virus post-transcriptional regulatory elementpUC ori}pUC ori is equivalent to pBR322 ori; the origin of replication (ori) was derived originally from a ColE1-like plasmid, pMB1  D>ΚJQ?{ ()(HP$  <% ():D >>ܽ ()=D >b>N ؾ̽- ())M@8>D8 .. ʾiR ()y:  #D  /. ()B $ s ()^ D /D/( @.] ()LRDL00@?+ ()XbaI_Isoschizomer with BspAAII, BspLU11II, BsrXI, and Msp23I. Available from Invitrogen Corporation (8/08), Minotech Biotechnology (8/08), Fermentas International Inc. (8/08), American Allied Biochemical, Inc. (8/08), SibEnzyme Ltd. (8/08), Nippon Gene Co., Ltd. (8/08), Takara Bio Inc. (8/08), Roche Applied Science (8/08), New England Biolabs (8/08), Toyobo Biochemicals (8/08), Molecular Biology Resources - CHIMERx (8/08), Promega Corporation (8/08), Sigma Chemical Corporation (8/08), Bangalore Genei (8/08), Vivantis Technologies (8/08), MP Biomedicals (8/08), EURx Ltd. (8/08), and CinnaGen Inc. (8/08). PacIXhoIIsoschizomer with AbrI, AerAI, AhyAI, AlwFII, Asp15I, Asp47I, Asp703I, BadI, BbfI, BbiIII, BluI, Bsp92I, Bsp129I, Bsp139I, Bsp140I, Bsp141I, Bsp142I, BspAAI, BssHI, BstHI, BstLI, BstVI, BsuMI, BthI, CcrI, CjaI, DdeII, DrdDI, Eae2I, EscI, MavI, McaI, MecI, MhaI, MlaAI, MpuI, MrhI, MscAI, MsiI, Msp23II, OcoI, PaeR7I, PanI, Pfl67I, PflNI, PflWI, Psp4I, PspNI, Sal1974I, Sau3239I, SauLPII, Sbi68I, Sca1827I, SciI, Sci1831I, SciBI, ScuI, SdiAI, SexI, Sfr274I, Sfu1762I, SgaI, SgoI, Sgr1841I, Shy1766I, SlaI, SluI, Sol10179I, SpaI, Sph1719I, SrifpI, Ssp4I, StaAI, StrI, Sve194I, TliI, Uba1130I, Uba1148I, Uba1154I, Uba1166I, Uba1237I, Uba1248I, Uba1271I, Uba1298I, Uba1335I, Uba1397I, Uba1448I, and XpaI. Available from Invitrogen Corporation (8/08), Fermentas International Inc. (8/08), American Allied Biochemical, Inc. (8/08), Nippon Gene Co., Ltd. (8/08), Takara Bio Inc. (8/08), Roche Applied Science (8/08), New England Biolabs (8/08), Toyobo Biochemicals (8/08), Molecular Biology Resources - CHIMERx (8/08), Promega Corporation (8/08), Sigma Chemical Corporation (8/08), Bangalore Genei (8/08), MP Biomedicals (8/08), EURx Ltd. (8/08), and CinnaGen Inc. (8/08). AgeIIsoschizomer with AsiAI, AsiGI, BshTI, CsiAI, CspAI, and PinAI. Available from Nippon Gene Co., Ltd. (8/08), New England Biolabs (8/08), and Promega Corporation (8/08). ClaIsIsoschizomer with AagI, Apu16I, Asp14I, Asp37I, Asp86I, Asp123I, Asp130I, Asp707I, BanIII, BavCI, BazI, BbvAII, Bci29I, BciBI, BcmI, Bco79I, BdiI, BfrAI, Bli41I, Bli86I, Bli576I, Bli585I, BliAI, BliRI, Bsa29I, BscI, BscVI, BseCI, Bsh108AI, BshVI, BsiXI, Bsp2I, Bsp4I, Bsp84I, Bsp106I, Bsp125I, Bsp126I, Bsp127I, Bsp145I, BspDI, BspJII, BspOVII, BspXI, BspZEI, BsrCI, Bst28I, BstLVI, BstNZ169I, Bsu15I, BsuTUI, Bth1202I, Bth9415I, BtuI, Csp4I, LcaI, LplI, PgaI, Rme21I, SpmI, Ssp27144I, Uba22I, Uba24I, Uba30I, Uba34I, Uba43I, Uba1096I, Uba1100I, Uba1133I, Uba1137I, Uba1138I, Uba1144I, Uba1145I, Uba1161I, Uba1168I, Uba1195I, Uba1196I, Uba1197I, Uba1198I, Uba1199I, Uba1200I, Uba1233I, Uba1238I, Uba1246I, Uba1257I, Uba1275I, Uba1286I, Uba1295I, Uba1315I, Uba1342I, Uba1366II, Uba1379I, Uba1380I, Uba1394I, Uba1412I, Uba1416I, Uba1427I, Uba1430I, Uba1451I, Uba1453I, and ZhoI. Available from Invitrogen Corporation (8/08), American Allied Biochemical, Inc. (8/08), Takara Bio Inc. (8/08), Roche Applied Science (8/08), New England Biolabs (8/08), Promega Corporation (8/08), Sigma Chemical Corporation (8/08), and Bangalore Genei (8/08). XbaI_Isoschizomer with BspAAII, BspLU11II, BsrXI, and Msp23I. Available from Invitrogen Corporation (8/08), Minotech Biotechnology (8/08), Fermentas International Inc. (8/08), American Allied Biochemical, Inc. (8/08), SibEnzyme Ltd. (8/08), Nippon Gene Co., Ltd. (8/08), Takara Bio Inc. (8/08), Roche Applied Science (8/08), New England Biolabs (8/08), Toyobo Biochemicals (8/08), Molecular Biology Resources - CHIMERx (8/08), Promega Corporation (8/08), Sigma Chemical Corporation (8/08), Bangalore Genei (8/08), Vivantis Technologies (8/08), MP Biomedicals (8/08), EURx Ltd. (8/08), and CinnaGen Inc. (8/08). BamHI5Isoschizomer with AacI, AaeI, AcaII, AccEBI, AinII, AliI, Ali12257I, Ali12258I, ApaCI, AsiI, AspTII, Atu1II, BamFI, BamKI, BamNI, Bca1259I, Bce751I, Bco10278I, BnaI, BsaDI, Bsp30I, Bsp46I, Bsp90II, Bsp98I, Bsp130I, Bsp131I, Bsp144I, Bsp4009I, BspAAIII, BstI, Bst1126I, Bst2464I, Bst2902I, BstQI, Bsu90I, Bsu8565I, Bsu8646I, BsuB519I, BsuB763I, CelI, DdsI, GdoI, GinI, GoxI, GseIII, GstI, MleI, Mlu23I, NasBI, Nsp29132II, NspSAIV, OkrAI, Pac1110I, Pae177I, Pfl8I, Psp56I, RhsI, Rlu4I, RspLKII, SolI, SpvI, SurI, Uba19I, Uba31I, Uba38I, Uba51I, Uba88I, Uba1098I, Uba1163I, Uba1167I, Uba1172I, Uba1173I, Uba1205I, Uba1224I, Uba1242I, Uba1250I, Uba1258I, Uba1297I, Uba1302I, Uba1324I, Uba1325I, Uba1334I, Uba1339I, Uba1346I, Uba1383I, Uba1398I, Uba1402I, Uba1414I, Uba4009I, and UbaN3I. Available from Invitrogen Corporation (8/08), Minotech Biotechnology (8/08), Fermentas International Inc. (8/08), American Allied Biochemical, Inc. (8/08), SibEnzyme Ltd. (8/08), Nippon Gene Co., Ltd. (8/08), Takara Bio Inc. (8/08), Roche Applied Science (8/08), New England Biolabs (8/08), Toyobo Biochemicals (8/08), Molecular Biology Resources - CHIMERx (8/08), Promega Corporation (8/08), Sigma Chemical Corporation (8/08), Bangalore Genei (8/08), Vivantis Technologies (8/08), MP Biomedicals (8/08), EURx Ltd. (8/08), and CinnaGen Inc. (8/08). EcoRIIsoschizomer with Eco82I, Eco159I, Eco228I, Eco237I, Eco252I, FunII, HalI, Hal22I, Kpn49kI, Ppu111I, RsrI, Srl32DII, Srl55DI, SsoI, Uba58I, Van91II, VchN100I, and VchO2I. Available from Invitrogen Corporation (8/08), Minotech Biotechnology (8/08), Fermentas International Inc. (8/08), American Allied Biochemical, Inc. (8/08), SibEnzyme Ltd. (8/08), Nippon Gene Co., Ltd. (8/08), Takara Bio Inc. (8/08), Roche Applied Science (8/08), New England Biolabs (8/08), Toyobo Biochemicals (8/08), Molecular Biology Resources - CHIMERx (8/08), Promega Corporation (8/08), Sigma Chemical Corporation (8/08), Bangalore Genei (8/08), Vivantis Technologies (8/08), MP Biomedicals (8/08), EURx Ltd. (8/08), and CinnaGen Inc. (8/08). XhoIIsoschizomer with AbrI, AerAI, AhyAI, AlwFII, Asp15I, Asp47I, Asp703I, BadI, BbfI, BbiIII, BluI, Bsp92I, Bsp129I, Bsp139I, Bsp140I, Bsp141I, Bsp142I, BspAAI, BssHI, BstHI, BstLI, BstVI, BsuMI, BthI, CcrI, CjaI, DdeII, DrdDI, Eae2I, EscI, MavI, McaI, MecI, MhaI, MlaAI, MpuI, MrhI, MscAI, MsiI, Msp23II, OcoI, PaeR7I, PanI, Pfl67I, PflNI, PflWI, Psp4I, PspNI, Sal1974I, Sau3239I, SauLPII, Sbi68I, Sca1827I, SciI, Sci1831I, SciBI, ScuI, SdiAI, SexI, Sfr274I, Sfu1762I, SgaI, SgoI, Sgr1841I, Shy1766I, SlaI, SluI, Sol10179I, SpaI, Sph1719I, SrifpI, Ssp4I, StaAI, StrI, Sve194I, TliI, Uba1130I, Uba1148I, Uba1154I, Uba1166I, Uba1237I, Uba1248I, Uba1271I, Uba1298I, Uba1335I, Uba1397I, Uba1448I, and XpaI. Available from Invitrogen Corporation (8/08), Fermentas International Inc. (8/08), American Allied Biochemical, Inc. (8/08), Nippon Gene Co., Ltd. (8/08), Takara Bio Inc. (8/08), Roche Applied Science (8/08), New England Biolabs (8/08), Toyobo Biochemicals (8/08), Molecular Biology Resources - CHIMERx (8/08), Promega Corporation (8/08), Sigma Chemical Corporation (8/08), Bangalore Genei (8/08), MP Biomedicals (8/08), EURx Ltd. (8/08), and CinnaGen Inc. (8/08). First Generation  >r () =,R]   ()XTTAATTAAggatccpMOWS-LAT Nex5-GFP7Toolbox verified plasmid via restriction digest 10-2009P Standard Codon Table       (B@HѢ () *? E9B((71.562)$$